LUNG cancer is one of the four most common cancers in the UK alongside breast, bowel, and prostate cancer. It is also a cancer with one of the lowest survival rates in the UK. However, in a boost to patients, a new drug capable of doubling life expectancy has been approved for use on the NHS.
Daily Express :: Health Feed